| Product Code: ETC7738875 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Gastric Cancer Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Gastric Cancer Market - Industry Life Cycle |
3.4 Japan Gastric Cancer Market - Porter's Five Forces |
3.5 Japan Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Japan Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Japan Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Japan Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Japan Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Japan Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in Japan |
4.2.2 Rising adoption of advanced diagnostic technologies |
4.2.3 Growing awareness about early detection and treatment of gastric cancer |
4.3 Market Restraints |
4.3.1 High treatment costs associated with gastric cancer |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Japan |
4.3.3 Stringent regulatory requirements for approval of new treatment options |
5 Japan Gastric Cancer Market Trends |
6 Japan Gastric Cancer Market, By Types |
6.1 Japan Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Japan Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Japan Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Japan Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Japan Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Japan Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Japan Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Japan Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Japan Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 Japan Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Japan Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 Japan Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 Japan Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Japan Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 Japan Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Japan Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 Japan Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Japan Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Japan Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 Japan Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 Japan Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 Japan Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Japan Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Japan Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Japan Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Japan Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Japan Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Japan Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Japan Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 Japan Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Japan Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Japan Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Japan Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Japan Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 Japan Gastric Cancer Market Import-Export Trade Statistics |
7.1 Japan Gastric Cancer Market Export to Major Countries |
7.2 Japan Gastric Cancer Market Imports from Major Countries |
8 Japan Gastric Cancer Market Key Performance Indicators |
8.1 Survival rates of gastric cancer patients in Japan |
8.2 Adoption rate of screening programs for early detection |
8.3 Number of research studies and clinical trials focused on gastric cancer in Japan |
9 Japan Gastric Cancer Market - Opportunity Assessment |
9.1 Japan Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Japan Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Japan Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 Japan Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Japan Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Japan Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Gastric Cancer Market - Competitive Landscape |
10.1 Japan Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 Japan Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here